Abstract
We report the clinical presentation and genetic screening of a 31-year-old man with dilatation of the aortic root and ascending aorta and a positive family history for aortic dissection and sudden death. A novel heterozygous variant in a splice acceptor site (c.1600-1G>T) of TGFβR2 gene was identified by using a targeted multi-gene panel analysis. Bioinformatics tools predicted that the c.1600-1G>T variant is pathogenic by altering acceptor splice site at − 1 position affecting pre-mRNA splicing. These data confirm that the diverging splicing in the TGF-β pathway genes may be an important process in aneurismal disease and emphasize the utility of genetic sequencing in the identification of high-risk patients for a more patient’s management able to improve outcomes and minimize costs for the care of patients with heritable thoracic aortic aneurysm and dissection.
References
- 1. Genes associated with thoracic aortic aneurysm and dissection: 2018 update and clinical implications. Aorta (Stamford) 2018;6:13–20.
doi: 10.1055/s-0038-1639612 - 2. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2022;80:e223–e393.
https://doi.org/10.1161/CIR.0000000000001106 - 3. . Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett. 2005;579:1900–1903.
doi: 10.1016/j.febslet.2005.02.047 - 4. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 2004;36:855–860.
doi: 10.1038/ng1392 - 5. . Diverging alternative splicing fingerprints in the transforming growth factor-β signaling pathway identified in thoracic aortic aneurysms. Mol. Med. 2011;17:665–675.
doi: 10.2119/molmed.2011.00018 - 6. Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome. J. Vasc. Surg. 2018;68:225–233.e5.
doi: 10.1016/j.jvs.2017.04.071 - 7. . Novel TGFBR2 and known missense SMAD3 mutations: two case reports of thoracic aortic aneurysms. Ann. Thorac. Surg. 2015;99:303–305.
doi: 10.1016/j.athoracsur.2014.02.068 - 8. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys–Dietz syndrome and related disorders. Hum. Mutat. 2008;29:e284–e295.
doi: 10.1002/humu.20871 - 9. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys–Dietz syndrome. Hum. Mutat. 2006;27:770–777.
doi: 10.1002/humu.20354 - 10. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005;112:513–520.
- 11. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J. Med. Genet. 2009;46:607–613.
doi: 10.1136/jmg.2008.062844 - 12. International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: results of the MAC (Montalcino Aortic Consortium). Circ. Cardiovasc. Genet. 2016;9:548–558.
doi: 10.1161/CIRCGENETICS.116.001485 - 13. Surgical outcome and histological differences between individuals with TGFBR1 and TGFBR2 mutations in Loeys–Dietz syndrome. Ann. Thorac. Cardiovasc. Surg. 2021;27:56–63.
doi: 10.5761/atcs.oa.20-00223